Dermatomyositis exacerbated by abdominal Marlex mesh implantation: adjuvant effect?
We describe a 35-year-old woman with dermatomyositis, who four months after implantation of abdominal Marlex mesh, developed a severe exacerbation of her disease with muscle weakness, elevated acute-phase reactants, a high level of muscle enzymes, and the appearance of dermal lesions with calcinosis. The Marlex mesh implant may have triggered the flare-up of her underlying autoimmune disorder.
Bernard-Medina
G
G
Gutierrez-Urena
S
S
Orozco-Alcala
J
J
D000328:Adult; D001707:Biopsy, Needle; D003402:Creatine Kinase / Q000378:metabolism; D003882:Dermatomyositis / Q000175:diagnosis / Q000201:enzymology / Q000209:etiology* / Q000503:physiopathology; D018450:Disease Progression; D004576:Electromyography; D005260:Female; D059685:Herniorrhaphy; D006801:Humans; D011095:Polyethylenes / Q000009:adverse effects*; D011126:Polypropylenes / Q000009:adverse effects*; D013526:Surgical Mesh / Q000009:adverse effects
C016674:Plastipore; D011095:Polyethylenes; D011126:Polypropylenes; D003402:Creatine Kinase